Key Points
- Circle 2 Sponsor Corp Columbus, a major shareholder, purchased 265,000 shares of CM Life Sciences II on Feb. 12 at an average price of $10.00 per share, totaling $2.65 million.
- The transaction was disclosed in an SEC filing and left the insider owning 265,000 shares — recorded as an "∞ increase," indicating the purchase established a new position.
- CM Life Sciences II is a Delaware-registered SPAC targeting life-sciences acquisitions; its units trade OTC under CMIIU and are trading around $9.99–$10.02 with 50- and 200-day moving averages near $11.1.
CM Life Sciences II Inc. (OTCMKTS:CMIIU - Get Free Report) major shareholder Circle 2 Sponsor Corp Columbus bought 265,000 shares of the stock in a transaction that occurred on Thursday, February 12th. The stock was bought at an average cost of $10.00 per share, for a total transaction of $2,650,000.00. Following the transaction, the insider owned 265,000 shares of the company's stock, valued at $2,650,000. The trade was a ∞ increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Major shareholders that own more than 10% of a company's stock are required to disclose their sales and purchases with the SEC.
CM Life Sciences II Stock Down 0.1%
CMIIU opened at $9.99 on Wednesday. The business has a 50 day moving average of $11.10 and a 200-day moving average of $11.18. CM Life Sciences II Inc. has a 12-month low of $9.99 and a 12-month high of $10.02.
CM Life Sciences II Company Profile
(
Get Free Report)
CM Life Sciences II, Inc is a special purpose acquisition company (SPAC) incorporated in Delaware in February 2021. The company's units trade on the OTC market under the ticker CMIIU. As a blank‐check company, CM Life Sciences II seeks to identify and acquire one or more businesses in the life sciences industry, including biotechnology, biopharmaceuticals, medical devices and related areas.
The company raised capital through its initial public offering in mid-2021, issuing public units each comprising one share of Class A common stock and a fraction of a warrant.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
